Nuvation Bio Inc.

NYSE: NUVB · Real-Time Price · USD
2.17
-0.02 (-0.91%)
At close: May 14, 2025, 3:59 PM
2.16
-0.23%
Pre-market: May 15, 2025, 04:09 AM EDT

Nuvation Bio Revenue Breakdown

Period Ending Dec 31, 2024
License Revenue Revenue 2.09M
License Revenue Revenue Growth n/a

Operating Expense Breakdown

Period Ending Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Selling, General, and Administrative Revenue 26.14M 19.58M 15.91M 7.3M 5.42M 7.78M 7.54M 7.73M 7.46M 8.04M 8.95M 7.46M 7.61M 5.67M 6.4M 4.61M 4.43M 2.92M 1.67M 1.93M 1.82M 1.44M 1.87M 1.87M
Selling, General, and Administrative Revenue Growth +33.48% +23.06% +118.00% +34.54% -30.25% +3.14% -2.50% +3.62% -7.21% -10.10% +19.90% -1.89% +34.19% -11.42% +38.98% +3.90% +51.83% +74.58% -13.14% +5.71% +26.55% -22.90% 0.00% n/a
Research and Development Revenue 29.3M 27.73M 29.25M 12.84M 15.35M 18.56M 18.59M 18.79M 16.87M 21.29M 28.92M 20.73M 22M 17.12M 14.03M 15.88M 9.34M 8.63M 7.34M 7.29M 8.8M 4.04M 6.13M 6.13M
Research and Development Revenue Growth +5.65% -5.18% +127.74% -16.34% -17.29% -0.16% -1.05% +11.36% -20.77% -26.37% +39.52% -5.79% +28.50% +22.00% -11.62% +70.08% +8.22% +17.45% +0.69% -17.10% +118.04% -34.21% 0.00% n/a